Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-13.76 Insider Own2.25% Shs Outstand0.54M Perf Week32.25%
Market Cap2.19M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.53M Perf Month47.10%
Income-5.16M PEG- EPS next Q- Inst Own7.59% Short Float3.90% Perf Quarter-15.42%
Sales0.00M P/S- EPS this Y- Inst Trans-65.24% Short Ratio0.04 Perf Half Y-30.00%
Book/sh-9.47 P/B- EPS next Y- ROA-25.58% Short Interest0.02M Perf Year-74.47%
Cash/sh9.20 P/C0.44 EPS next 5Y- ROE- 52W Range2.23 - 18.70 Perf YTD-31.81%
Dividend Est.- P/FCF- EPS past 5Y46.35% ROI-34.12% 52W High-78.29% Beta2.51
Dividend TTM- Quick Ratio3.06 Sales past 5Y0.00% Gross Margin- 52W Low82.06% ATR (14)0.57
Dividend Ex-Date- Current Ratio2.73 EPS Y/Y TTM76.62% Oper. Margin0.00% RSI (14)58.36 Volatility13.48% 19.40%
Employees31 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price700.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q59.70% Payout- Rel Volume0.42 Prev Close3.44
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsJul 02 BMO Avg Volume557.06K Price4.06
SMA2022.32% SMA508.70% SMA200-24.68% Trades Volume233,387 Change18.02%
Jul-08-24 08:14AM
Jul-03-24 09:32AM
Jul-02-24 01:52PM
Jun-21-24 07:52AM
07:56AM Loading…
Jun-17-24 07:56AM
Jun-13-24 07:00AM
Jun-07-24 07:00AM
Jun-03-24 10:52AM
May-24-24 04:01PM
May-15-24 04:01PM
May-06-24 09:21AM
Apr-10-24 07:00AM
Apr-08-24 07:00AM
08:00AM Loading…
Mar-12-24 08:00AM
Feb-29-24 08:45AM
Feb-13-24 07:00AM
Jan-25-24 10:26AM
Jan-04-24 04:01PM
Dec-29-23 09:21AM
Dec-27-23 07:15AM
Dec-20-23 08:05AM
Dec-12-23 07:26AM
Dec-11-23 08:11AM
Nov-29-23 09:25AM
Nov-20-23 07:30AM
Nov-06-23 07:30AM
Nov-03-23 04:30PM
09:00AM Loading…
Oct-31-23 09:00AM
Oct-30-23 07:00AM
Oct-04-23 07:30AM
Sep-19-23 04:05PM
Sep-15-23 09:01AM
Sep-13-23 04:13PM
Sep-11-23 07:30AM
Sep-06-23 06:00AM
Aug-11-23 09:00AM
Aug-01-23 04:01PM
Jul-11-23 08:17AM
Jun-05-23 07:00AM
May-30-23 06:00AM
May-15-23 04:45PM
Apr-17-23 04:25PM
Mar-16-23 01:10PM
Mar-06-23 01:31PM
Mar-03-23 02:07PM
Feb-02-23 02:15PM
Jan-23-23 11:50AM
Jan-06-23 07:15AM
Jan-05-23 07:00AM
Dec-30-22 07:30AM
Dec-21-22 11:00AM
Dec-20-22 12:42PM
Dec-16-22 08:48AM
Dec-12-22 07:06AM
Dec-08-22 11:05AM
Dec-06-22 08:30AM
Nov-30-22 09:15AM
Nov-29-22 07:00AM
Nov-21-22 06:00AM
Nov-15-22 08:33AM
Nov-10-22 04:00PM
Nov-03-22 11:30AM
Nov-02-22 04:30PM
Oct-18-22 07:55AM
Oct-11-22 02:00PM
Sep-30-22 07:33AM
Sep-22-22 09:05AM
Sep-20-22 06:15AM
Sep-08-22 09:13AM
Aug-25-22 07:30AM
Aug-10-22 08:33AM
Jun-27-22 10:22AM
Jun-07-22 08:41AM
Jun-01-22 07:10AM
May-19-22 11:17AM
May-12-22 06:30AM
May-09-22 06:00AM
May-02-22 10:15AM
Apr-05-22 06:49AM
Mar-31-22 04:00PM
Mar-28-22 07:00AM
Mar-24-22 09:45AM
Mar-14-22 08:31AM
Feb-22-22 08:44AM
Feb-15-22 08:31AM
Feb-10-22 04:30AM
Jan-26-22 07:39AM
Jan-10-22 07:00AM
Jan-03-22 10:15AM
Dec-29-21 04:01PM
Dec-27-21 04:01PM
Dec-23-21 08:01PM
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.